(Q45749344)

15 December 2017

title

Cost-effectiveness of transfusing virus-inactivated plasma instead of standard plasma (English)

1 reference

15 December 2017

cost-effectiveness analysis

main subject

1 reference

Pereira A

1

1 reference

15 December 2017

publication date

1 May 1999

1 reference

15 December 2017

published in

Transfusion

1 reference

15 December 2017

volume

39

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

479-487

1 reference

15 December 2017

The cost effectiveness of preoperative autologous blood donations

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

The lifetime cost of treating a person with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Survival with AIDS in Ireland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

The Markov process in medical prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Current status of solvent/detergent-treated frozen plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Virus inactivation of fresh frozen plasma by a solvent detergent procedure: biological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Mammalian genotoxicity assessment of methylene blue in plasma: implications for virus inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.1999.39050479.X

10.1046/J.1537-2995.1999.39050479.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017